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In recent years, 5-aminolevulinic acid (ALA)-mediated photo-
dynamic therapy (PDT) has become one of the most promising
field in PDT research. ALA is the pro-drug of the photosensitizer
protoporphyrin IX (PPIX). After ALA administration, cells
generate PPIX through the haem biosynthetic pathway. The main
advantage of PPIX relative to other photosensitizers is the short
half-life of its photosensitizing effects, which do not last longer
than 48 h (Kennedy et al, 1990; Fukuda et al, 1993). Besides,
ALA-induced porphyrin fluorescence may also assist in the early
detection of some malignancies (Kriegmair et al, 1996). 
ALA-based PDT is also showing promise in the treatment of other
dermatological disorders such as nonmelanoma skin cancer, patch
and plaque stage cutaneous T-cell lymphoma, psoriasis and alopecia
areata (Lui and Anderson, 1992; Oseroff, 1993). In addition, other
cancer types such as lung (Baumgartner et al, 1996), bladder
(Jichlinski et al, 1997), oral cavity (Fan et al, 1996), oesophagus
(Gossner et al, 1998), endometrious (Wyss et al, 1998) and brain
(Stummer et al, 1998) have been recently treated with ALA-PDT. 
The hydrophilic nature of the ALA molecule limits somehow the
penetration through the straum corneum of the skin. Hence, ALA-
induced PPIX formation is often restricted to superficial tissue
layers because of both inhomogeneous and partial tissue distribu-
tion in deeper-lying or nodular lessions. Different approaches are
currently under investigation to enhance penetration, such as the
application of ALA in various vehicles and the development of
new synthetic molecules derived from ALA. The importance of
the vehicle formulation in topical ALA-PDT has been extensively
studied by Casas et al (2000). 
The use of more lipophilic derivatives of ALA was expected to
have better diffusing properties, and after conversion into the
parent ALA by enzymatic hydrolysis, to reach a higher PPIX
formation rate. 
Kloek et al (1996, 1998) synthesized a range of ALA esters
using alcohols of increasing carbon chain length, and demon-
strated in cell lines and animal models, that several ALA pro-drugs
are capable of being taken up, desterified and converted into PPIX
with higher efficiency than ALA itself. Gaullier et al (1997) found
that long-chained ALA esters reduced 30–150-fold the amount of
ALA needed to reach the same level of PPIX accumulation as that
obtained with non-esterified ALA in a human cell line, whereas
short-chained pro-ALAs were less efficient than ALA. 
Some esterified ALA derivatives have been used in normal
mouse skin (Peng et al, 1996), in human basal cell carcinomas
(Peng et al, 1995) and in human bladder tumours (Lange et al,
1996) and a higher and more homogeneous tissue distribution was
produced when compared to that of free ALA-induced porphyrins. 
Regarding the subcellular target of PDT damage induced by
photodynamic treatment, it is well known that singlet oxygen and
other reactive oxygen species lead to lipid peroxidation and
damage to biological membranes, DNA, cytoskeleton, etc. (Moan
and Berg, 1992). But the final mechanism of cell death may be
either necrosis or apoptosis, depending on the photosensitizer,
concentration and time of exposure, light dose, light source and
cell type (He et al, 1994; Dellinger, 1996; Noodt et al, 1996;
Miyamoto et al, 1999). Activation of phospholipases (Agarwall
et al, 1993) and caspases (He et al, 1998) have been shown to be
involved in the PDT-induced apoptotic process. 
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doi: 10.1054/ bjoc.2001.1875, available online at http://www.idealibrary.com on  http://www.bjcancer.comWebber et al (1996) reported an apoptotic response to PDT
performed in vivo in a murine colon adenocarcinoma with endoge-
nously formed PPIX from ALA. Noodt et al (1996) observed that
some cell lines exposed to ALA-PDT die mainly by necrosis,
whereas others die by apoptosis, yet there have been no reports on
the type of cytotoxicity induced by ALA-pro-drugs. 
Here we have analysed the behaviour of 3 ALA derivatives
(ALA methly-ester, hexyl ester and a 2-sided derivative) that had
been previously tested in rat and human skin explants (Casas et al,
1999) regarding PPIX formation and their efficiency in sensitizing
cells to photoinactivation. The mechanism of cellular death
induced by ALA and ALA derivatives is also discussed. 
MATERIALS AND METHODS 
Cell line and cell culture 
Cell line LM2 (Galli et al, 2000) derived from the murine
mammary adenocarcinoma M2 was cultured in minimum essential
Eagle’s medium (MEM), supplemented with 2 mM L-glutamine,
40 mg gentamycin ml–1 and 5% fetal bovine serum (FBS), and
incubated at 37°C in an atmosphere containing 5% CO2. 
Chemicals 
ALA and ALA-methyl-ester (Me-ALA) were obtained from Sigma
Chem Co; ALA-Hexyl ester (He-ALA) and Carbobenzoyloxy-D-
phenyl-alanyl-5-ALA-ethyl ester (CDF-ALA) were synthesized
according to the procedures described in Casas et al (1999). 
ALA, Me-ALA and He-ALA were dissolved in saline. CDF-
ALA was dissolved in DMSO in a concentration such that 0.6 mM
CDF-ALA corresponds to 0.66 mM DMSO. ALA and ALA deriv-
atives solutions were sterilized by filtration through 0.21 mm pore
size filters. Addition of either ALA or ALA derivatives to cells did
not change the pH of the medium. 
Laser irradiations 
Cells were incubated in serum-free medium containing ALA or
ALA derivatives, and 3 h later, laser irradiations were performed.
After 5 minutes of irradiation, medium was replaced by ALA-free
medium + FBS, the cells were incubated for another 19 h and then
tested for viability. Irradiations were performed employing a
rhodamine dye laser (Model DL30, Oxford Lasers) pumped by a
copper vapour laser (CU15A, Oxford Lasers) tuned to 630 nm.
The light was focused into a 400-mm-diameter optical fibre
coupled to a frontal light distributor (Model FD2, Medlight,
Ecublens, Switzerland) to produce a treatment area of uniform
intensity. The output power from the fibre was measured with a
power meter (Model LM-100XL, Coherent, Auburn, CA) before
each application, and adjusted to the desired light dose. 
MTT viability assay 
Phototoxicity/toxicity was documented by the MTT assay
(Denizot and lang, 1986). Following appropriate treatments, MTT
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide)
solution was added to each well in a concentration of 0.5 mg ml–1,
and plates were incubated at 37°C for 1 h. The resulting formazan
crystals were dissolved by the addition of DMSO and absorbance
was read at 560 nm. 
Measurement of porphyrin synthesis 
Cells were exposed to ALA or ALA derivatives in serum-free
medium. After incubation, porphyrins accumulated within the
cells were extracted twice with 5% HCl, leaving the cells for half
an hour in the presence of the acid. These conditions proved to
be the optima for total PPIX extraction. The media were acidi-
fied and measured directly fluorometrically. The excitation and
emission wavelengths of light used producing the highest fluo-
rescence were 406 nm and 604 nm respectively. PpIX (Porphyrin
Products, Logan, Utah, USA) was used as a reference standard. 
Cell number 
The number of cells seeded per well and the cell number employed
for the calculations of porphyrins per cell were determined by
counting viable cells with the Trypan blue exclusion method. 
Analysis of DNA fragmentation 
The cells treated with PDT, attached and unattached, were
harvested 19 h after treatment. The pellets were washed in phos-
phate-buffered saline, resuspended in TNE (10 mM Tris-HCl, pH
7.6; 1 mM EDTA; and 140 mM NaCl) and lysed at 37°C in 1 ml of
extraction buffer (10 mM Tris-HCl, pH 8.0; 100 mM EDTA,
pH 8.0; 20 mg ml–1 pancreatic RNAse and 0.5% SDS). After 2 h,
proteinase K was added at a final concentration of 100 mgm l –1 and
the mixture was incubated for another 3 h at 50°C. The DNA was
extracted twice with equal volumes of phenol and once with
chloroform. The DNA was then precipitated with 0.1 vol of
sodium acetate (pH 4.8) and 2.5 vol of ethanol at –20°C overnight
and pelleted at 14.000 g for 30 min. Samples were electrophoresed
in a 2% agarose gel for approximately 2.5 h at 100 V and DNA
was visualized by ethidium bromide staining. 
Morphological studies 
The cells were seeded in cover slips, treated with PDT as indicated
above, and after 19 h they were stained with acridine orange
(5 mg ml–1). The samples were washed with MEM, then the cover
slips inverted on a slide and fluorescence was observed exciting
the sample at 450–490 nm and employing the 510 nm dichroic
mirror and 520 nm high-pass filter. 
Statistical treatment 
The values are expressed in the figures as mean ± standard error of
the mean and they are the average of 3 independent experiments
run in triplicate. 
RESULTS 
Cell, time and ALA concentration dependence 
Maximal porphyrin synthesis with 0.6 mM ALA-and 3 h incuba-
tion was observed between 3 and 3.5 ´ 104 cells. When the cell
number was increased above 3.5 ´ 104, a slight decrease in the
tetrapyrrole synthesis per number of cells was found, and
employing a cell number below 3 ´ 104 cells, accumulation of
porphyrins was very low. 
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Figure 1. It was found that cellular porphyrin content increased
linearly during that period of time, indicating that no saturation of
enzymatic functions occurred. Similar profiles were obtained
using higher ALA concentrations. 
In Figure 2 we can observe that the rate of PPIX synthesized
increased with ALA or pro-ALA concentration, showing a
sigmoidal-profile on logaritmic scales, in the case of ALA and
ALA esters. CDF-ALA exhibited a peak at 0.2 mM, and then
porphyrins decreased to basal levels. 
The maximum amount of porphyrins synthesized from 0.6 mM
ALA was 47 ± 8 ng 10–5. The same amount was formed by a
concentration of He-ALA 60-fold lower (0.01 mM). Instead, 2-
fold higher Me-ALA (1.2 mM) was needed to reach PPIX biosyn-
thesis equal to that formed from 0.6 mM ALA. 
The highest PPIX biosynthesis obtained (expressed as ng 10–5
cells) was 75 ± 4 from 1 mM He-ALA, 47 ± 8 from 0.6 mM ALA,
48 ± 6 from 1.4 mM Me-ALA and 20 ± 5 from 0.2 mM CDF-ALA.
Increasing these concentrations, PPIX accumulation became lower
for He-ALA and CDF-ALA. Instead, ALA and Me-ALA maintained
a plateau after reaching their maximal level of porphyrins.
Porphyrins released to the media were about 10% of the amount
retained intracellularly at all the concentrations of ALA and ALA
esters assayed (data not shown). However, 50% of porphyrin
release was observed when CDF-ALA was employed at concen-
trations above 0.6 mM. 
In Figure 3 we can see that ALA and Me-ALA are not toxic for
the cells. On the other hand, He-ALA at concentrations higher than
The use of ALA derivatives in photodynamic therapy 281
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Figure 1 Porphyrin synthesis as a function of incubation time in the
presence of ALA. 3.5 ´ 104 cells per well were incubated during different time
periods in the presence of 0.6 mM ALA in 24-well plates. Intracellular
porphyrins were determined fluorimetrically and relativized per number of
cells present at the beginning of the experiment 
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Figure 2 Porphyrin synthesis from ALA and ALA derivatives. 3.5 ´ 104 cells
per well were incubated for 3 hours in the presence of different amounts of
ALA (l) or its derivatives Me-ALA (n), He-ALA (s) or CDF-ALA (t). 
All compounds were dissolved in water, except for CDF-ALA, which was
dissolved in DMSO. Intracellular porphyrins were determined fluorimetrically
and relativized per number of cells present at the beginning of the experiment 
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Figure 3 Dark toxicity of ALA and ALA derivatives. 3.5 ´ 104 cells per well
were incubated for 3 hours in the presence of different amounts of ALA (A),
Me-ALA (B), He-ALA (C) and CDF-ALA (D). Immediately after, the MTT
assay was performed. Cell survival was expressed as percentage of the
control not exposed to ALA 1.4 mM appeared to be cytotoxic in the dark. CDF-ALA induced a
concentration-dependent decrease on cell viability; with 1.2 mM
CDF-ALA, less than 40% of cells survive. This effect correlates
well with toxicity driven by the DMSO vehicle alone (data not
depicted). However, DMSO at concentrations lower than 5%
(corresponding to 0.6 mM CDF-ALA) exerted no cytotoxicity
measured by the MTT assay. 
PDT-induced cytotoxicity 
Survival of irradiated cells exposed to similar porphyrin concen-
tration proceeding form ALA or ALA derivatives is shown in
Table 1. When 0.6 J cm–2 light dose was used, cell viability
decreased approximately to 50% employing all ALA compounds.
With the 1.5 J cm–2 light dose, less than 20% of the cells survive.
Higher light doses produced almost total cell killing. No signifi-
cant differences between ALA and pro-ALAs were observed for
each light dose. 
Table 2 depicts the efficacy of PDT with increasing concentra-
tions of ALA and ALA derivatives. We can observe that using a
concentration as low as 0.005 mM of He-ALA, cell viability
decreases almost to 50%. Increasing the concentration of the
derivative to 0.01 mM, cell viability is further reduced, and only
1–3% of cells survive. To reach a similar rate of cell death
employing ALA, the concentration must be nearly 60 times higher
(0.3 mM ALA induces 50% of cell death). Moreover, when Me-
ALA was tested, we found that 0.3 mM of this derivative is neces-
sary to produce 80% of cell death. 
Evidence of apoptosis 
Gel electrophoresis was used to detect the appearance of nucleo-
some multimers after PDT treatment with ALA or ALA deriva-
tives (Figure 4). There was no evidence of internucleosomal
cleavage in non-treated cells or in cells treated with ALA, ALA
derivatives or light alone, and these lanes contained only high
molecular weight DNA. A small amount of necrosis-induced
random cut DNA of low molecular weight was detected in the
lanes of ALA or ALA derivative controls not exposed to light.
When cells were exposed to even low ALA or ALA derivatives
concentrations and to a rather high light dose (3 J cm–2) (Figure 4A),
we detected the typical ladder pattern of nucleosome multimers,
yielding 180-base pair integer fragments. In all PDT-treated cells,
a background of intranucleosomal cut DNA produced either by
necrosis and/or post-apoptotic necrosis processes was observed.
Applying light doses higher than 3 J cm–2, similar patterns were
obtained (data not shown). On the other hand, exposing cells to
half the light dose (1.5 J cm–2) no detectable evidence of nucleo-
some-sized fragments was found, independently on the ALA or
ALA derivative dose employed (Figure 4B). Intranucleosomal
random-cut DNA was also observed in all lanes. 
PDT-induced apoptosis was also investigated at the morpholog-
ical level by staining cells with acridine orange (Figure 5). Normal
chromatin was found in control cells, but condensed and frag-
mented nuclei and condensed cytoplasms were seen after PDT
with ALA or ALA derivatives. In addition, few cells can be
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Figure 4 Agarose gel electrophoresis of DNA from PDT-treated cells. Cells
were exposed 3 h to different concentrations of ALA or ALA derivatives and
irradiated with 3 J cm–2 (A) or 1.5 J cm–2 (B). Non-ALA treated and non-
irradiated controls were included. After 19 h DNA was extracted and
electrophoresed. The gels were stained with ethidium bromide and visualized
under 312 nm light 
Table 1 Cell survival after PDT with different light doses 
ALA He-ALA Me-ALA 
Control 100 ± 7 100 ± 7 100 ± 7 
0.6 J cm–2 45 ± 5.6 60 ± 8.2 55 ± 4.8 
1.5 J cm–2 18 ± 2.4 25 ± 3.1 27 ± 3.2 
3.0 J cm–2 4.1 ± 0.9 2.5 ± 0.9 2.0 ± 0.3 
15 J cm–2 3.9 ± 0.2 3.2 ± 0.6 2.5 ± 0.4 
18 J cm–2 2.8 ± 0.2 2.3 ± 0.1 3.0 ± 2.2 
PDT experiments were performed in 6 wells plates. Cells were incubated
with 0.6 mM ALA, 0.01 mM He-ALA or 1.2 mM Me-ALA (concentrations
producing similar porphyrin accumulation) in FBS-free medium during 3 h.
Immediately after, cells were irradiated with different light doses and
incubated in medium containing FBS for further 19 h. MTT assay was
performed and cell survival were expressed as percentage of the non-
irradiated control incubated in the presence of ALA or ALA derivative. 
Table 2 Cell survival after PDT with different ALA or ALA derivative
concentrations 
ALA He-ALA Me-ALA 
Control 100 ± 7 100 ± 7 100 ± 7 
0.005 mM 100 ± 8 54.9 ± 6 100 ± 9 
0.01 mM 100 ± 8 1.3 ± 0.3 100 ± 7 
0.05 mM 100 ± 5 2.5 ± 0.5 100 ± 7 
0.1 mM 95 ± 5 1.2 ± 0.7 100 ± 6 
0.2 mM 80 ± 3 1.3 ± 0.4 90 ± 5 
0.3 mM 50 ± 4 1.5 ± 0.25 85 ± 4 
PDT experiments were performed in 6 wells plates. Cells were incubated
with different concentrations of ALA, He-ALA or Me-ALA in FBS-free medium
during 3 h. Immediately after, cells were irradiated with 9 J cm–2 and
incubated in medium containing FBS for further 19 h. MTT assay was
performed and survival percentages were referred to the non-irradiated
control incubated in the presence of ALA or ALA derivative. observed 19 h after PDT treatment due to detachment of death
cells. Increasing ALA or ALA-derivative doses and light doses, a
greater number of apoptotic cells were observed. ALA alone or
light alone-treated cells also presented a normal diffusely stained
chromatin. 
DISCUSSION 
Our results show that the production of PPIX from exogenously
added ALA is cell density-dependent, in agreement with other
author’s reports (Steinbach et al, 1995; Gaullier et al, 1997). Using
human lung fibroblasts and colon adenocarcionoma cells, Moan
et al (1998) found a similar pattern to ours, and the number of
cells per area found to produce maximal porphyrin biosynthesis
was also within the same order as that reported here. 
The same amount of PPIX is formed by a concentration 60-fold
lower of He-ALA and 2-fold higher of Me-ALA than the ALA
concentration inducing maximal accumulation of porphyrins.
Similar results were observed by other authors with different cell
lines (Gaullier et al, 1997; Uehlinger et al, 2000). At their optimal
concentrations, ALA and Me-ALA formed an equal amount of
porphyrins while PPIX levels from He-ALA were 1.6 times
higher. However, we want to point out that the amount of PPIX
necessary to produce total cell killing in this model is much lower
than those reached under these optimal conditions. 
ALA and Me-ALA maintained a plateau after reaching their
maximal level of porphyrins. On the contrary, accumulation
became lower at high concentrations of He-ALA and CDF-ALA,
which corresponded well with dark toxic effects. In addition, the
higher release of PPIX when using CDF-ALA more than 0.2 mM,
may be ascribed to cell permeability changes driven by high
concentrations of the vehicle DMSO (Yyu and Quinn, 1998). In a
parallel set of experiments employing ALA and DMSO, we
confirmed that, in cells exposed to ALA, DMSO induced the same
rate of tetrapyrrole liberation (data not shown). 
In agreement with Washbrook and Riley (1997) and Kloek et al
(1998) findings, we showed that Me-ALA can not generate PPIX
amounts higher than those resulting from ALA. However, Fritsch
et al (1998) found that the ratio of porphyrins in solar keratoses
versus adjacent normal skin was higher when using this ester. So,
in spite of a lower efficiency of Me-ALA as a pro-photosensitizer,
better selectivity could result in an advantage which may be
exploited for the treatment of certain malignancies. 
All ALA compounds produced a plateau value of porphyrins at
different concentrations. In this regard, 2 processes: uptake and
ester cleavage are necessary for PPIX formation from ALA esters.
The facts that different carrier proteins appear to be involved in the
transport of ALA and ALA esters (Rud et al, 1999) and that some
specific esterases may be involved in the clevage of the different
ALA derivatives may be related to their dose-dependent efficacy
as pro-photosensitizers. 
Comparing the PPIX production with the induced phototoxicity,
we found that the more the porphyrin production, the greater the
cellular killing. Keeping in line with the findings of Gaullier et al
(1997) employing both human and animal cell cultures, we
observed here that PPIX formed from ALA and ALA-esters
equally sensitize the cells to photoinactivation. 
ALA-PDT treated cells exposed to rather high light doses,
exhibited morphological features typical of apoptosis, accompa-
nied by the characteristic internucleosomal DNA fragmentation,
independently on the pro-photosensitizer employed. These find-
ings are indicating that, after conversion into porphyrins, the
remaining ALA-esters or released alcohol chains do not interfere
with the mechanism of cytotoxicity induced by photosensitization.
The presence of a background smear of DNA, product of random
DNA digestion, in all cells PDT-treated with ALA or ALA esters,
suggests that necrosis is also induced, although we did not quantified
the proportion of cells dying by either necrosis or apoptosis.
Traces of random-cut DNA present in cells exposed to ALA or
ALA derivatives, suggest that some necrosis is induced by
The use of ALA derivatives in photodynamic therapy 283
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PDT treated cells Control cells
Figure 5 Fluorescence microscopy showing apoptotic cells. Cells were stained with acridine orange, 19 hours after photodynamic treatment with 0.1 mM He-
ALA and a light dose of 3 J cm–2. Similar images were obtained with ALA and Me-ALA. Control cells: non-ALA, non-light treated dark toxicity of these compounds, in spite that no significant
loss of viability was detected in the MTT assay at these concentra-
tions. 
Reducing the ALA dose required to induce a photosensitizing
effect would result in less side effects. Moreover, because the photo-
sensitizing efficacy of ALA-PDT depends on both the amount of
PPIX accumulated and the light dose applied, the fluence rate can be
substantially decreased if a higher accumulation of porphyrins is
reached by employing ALA derivatives, therefore improving ALA-
PDT. 
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